1. INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. WHO SHOULD READ THIS REPORT
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1 SECONDARY RESEARCH
1.4.2 DATA ANALYSIS FRAMEWORK
1.4.3 MARKET SIZE ESTIMATION
1.4.4 FORECASTING
1.4.5 PRIMARY RESEARCH AND DATA VALIDATION
2. ACNE MEDICATION MARKET – EXECUTIVE SUMMARY
2.1. MARKET SNAPSHOT, 2022 - 2030, MILLION USD
3. MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. MARKET DYNAMICS
3.2.1 DRIVERS
3.2.1.1 UNHEALTHY FOOD HABITS AND RISE IN SEDENTARY LIFESTYLES
3.2.1.2 OCCURRENCE OF ACNE VULGARIS CONDITION IN TEENAGERS & ADULTS
3.2.1.3 RISING AWARENESS ABOUT THE OVERALL APPEARANCE, HEALTH, AND ATTIRE
3.2.2 RESTRAINTS
3.2.2.1 SIDE-EFFECTS RELATED WITH THE USAGE OF ACNE MEDICATIONS AND SUBSTITUTE ACNE TREATMENT OPTIONS
3.2.3 OPPORTUNITIES
3.2.3.1 EMERGENCE & DEVELOPMENT OF EFFECTIVE ACNE MEDICATIONS WITH MINOR SIDE EFFECTS
3.2.3.2 SIGNIFICANT MARKET POTENTIAL IN UNTAPPED DEVELOPING COUNTRIES
4. COVID-19 ANALYSIS
4.1. IMPACT ON MARKET SIZE
4.2. END USER TRENDS & PREFERENCES, AND BUDGET & ECONOMIC IMPACT
4.3. KEY PLAYER STRATEGIES TO TACKLE COVID-19’S INFLUENCE ON MARKET
5. MARKET SHARE ANALYSIS
5.1. MARKET SHARE ANALYSIS OF TOP ACNE MEDICATION PROVIDERS, 2022
6. GLOBAL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS
6.1. OVERVIEW
6.2. RETINOIDS
6.2.1 GLOBAL RETINOIDS MARKET, BY THERAPEUTIC CLASS
6.2.1.1. TOPICAL RETINOID & COMBINATION RETIONOID MARKET, BY REGION
6.2.1.2. ORAL RETINOID (ISORETINION) MARKET, BY REGION
6.2.2 RETINOIDS MARKET, BY REGION
6.3. ANTIBIOTICS
6.3.1 GLOBAL ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS
6.3.1.1. TOPICAL ANTIBIOTIC & COMBINATION ANTIBIOTICS MARKET, BY REGION
6.3.1.2. ORAL ANTIBIOTIC MARKET, BY REGION
6.3.2 ANTIBIOTICS MARKET, BY REGION
6.4. SALICYLIC ACID
6.4.1 SALICYLIC ACID MARKET, BY REGION
6.5. BENZOYL PEROXIDE
6.5.1 BENZOYL PEROXIDE MARKET, BY REGION
6.6. OTHERS
6.6.1 GLOBAL OTHERS MARKET, BY THERAPEUTIC CLASS
6.6.1.1. OTHER TOPICALS (AZELAIC ACID) MARKET, BY REGION
6.6.1.2. OTHERS OTC MARKET, BY REGION
6.6.2 OTHERS MARKET, BY REGION
7. GLOBAL ACNE MEDICATION MARKET, BY FORMULATION
7.1. OVERVIEW
7.2. TOPICAL MEDICATIONS
7.2.1 TOPICAL MEDICATIONS MARKET, BY REGION
7.3. ORAL MEDICATIONS
7.3.1 ORAL MEDICATIONS MARKET, BY REGION
8. GLOBAL ACNE MEDICATION MARKET, BY TYPE
8.1. OVERVIEW
8.2. PRESCRIPTION MEDICINES
8.2.1 PRESCRIPTION MEDICINES MARKET, BY REGION
8.3. OVER-THE-COUNTER (OTC )MEDICINES
8.3.1 OVER-THE-COUNTER (OTC )MEDICINES MARKET, BY REGION
9. GLOBAL ACNE MEDICATION MARKET, BY ACNE TYPE
9.1. OVERVIEW
9.2. INFLAMMATORY ACNE
9.2.1 INFLAMMATORY ACNE MARKET, BY REGION
9.3. NON-INFLAMMATORY ACNE
9.3.1 NON-INFLAMMATORY ACNE MARKET, BY REGION
10. GLOBAL ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL
10.1. OVERVIEW
10.2. GROCERY SHOPS
10.2.1 GROCERY SHOPS MARKET, BY REGION
10.3. PHARMACIES & DRUG STORES
10.3.1 PHARMACIES & DRUG STORES MARKET, BY REGION
10.4. E-COMMERCE
10.4.1 E-COMMERCE MARKET, BY REGION
11. GLOBAL ACNE MEDICATION MARKET, BY REGION
11.1. OVERVIEW
11.2. NORTH AMERICA
11.2.1 NORTH AMERICA ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS
11.2.1.1. NORTH AMERICA RETINOIDS MARKET, BY THERAPEUTIC CLASS
11.2.1.2. NORTH AMERICA ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS
11.2.1.3. NORTH AMERICA OTHERS MARKET, BY THERAPEUTIC CLASS
11.2.2 NORTH AMERICA ACNE MEDICATION MARKET, BY FORMULATION
11.2.3 NORTH AMERICA ACNE MEDICATION MARKET, BY TYPE
11.2.4 NORTH AMERICA ACNE MEDICATION MARKET, BY ACNE TYPE
11.2.5 NORTH AMERICA ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL
11.2.6 NORTH AMERICA ACNE MEDICATION MARKET, BY COUNTRY
11.2.6.1. U.S.
11.2.6.1.1. U.S. ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS
11.2.6.1.1.1. U.S. RETINOIDS MARKET, BY THERAPEUTIC CLASS
11.2.6.1.1.2. U.S. ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS
11.2.6.1.1.3. U.S. OTHERS MARKET, BY THERAPEUTIC CLASS
11.2.6.1.2. U.S. ACNE MEDICATION MARKET, BY FORMULATION
11.2.6.1.3. U.S. ACNE MEDICATION MARKET, BY TYPE
11.2.6.1.4. U.S. ACNE MEDICATION MARKET, BY ACNE TYPE
11.2.6.1.5. U.S. ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL
11.2.6.2. CANADA
11.2.6.2.1. CANADA ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS
11.2.6.2.1.1. CANADA RETINOIDS MARKET, BY THERAPEUTIC CLASS
11.2.6.2.1.2. CANADA ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS
11.2.6.2.1.3. CANADA OTHERS MARKET, BY THERAPEUTIC CLASS
11.2.6.2.2. CANADA ACNE MEDICATION MARKET, BY FORMULATION
11.2.6.2.3. CANADA ACNE MEDICATION MARKET, BY TYPE
11.2.6.2.4. CANADA ACNE MEDICATION MARKET, BY ACNE TYPE
11.2.6.2.5. CANADA ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL
11.2.6.3. MEXICO
11.2.6.3.1. MEXICO ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS
11.2.6.3.1.1. MEXICO RETINOIDS MARKET, BY THERAPEUTIC CLASS
11.2.6.3.1.2. MEXICO ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS
11.2.6.3.1.3. MEXICO OTHERS MARKET, BY THERAPEUTIC CLASS
11.2.6.3.2. MEXICO ACNE MEDICATION MARKET, BY FORMULATION
11.2.6.3.3. MEXICO ACNE MEDICATION MARKET, BY TYPE
11.2.6.3.4. MEXICO ACNE MEDICATION MARKET, BY ACNE TYPE
11.2.6.3.5. MEXICO ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL
11.3. EUROPE
11.3.1 EUROPE ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS
11.3.1.1. EUROPE RETINOIDS MARKET, BY THERAPEUTIC CLASS
11.3.1.2. EUROPE ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS
11.3.1.3. EUROPE OTHERS MARKET, BY THERAPEUTIC CLASS
11.3.2 EUROPE ACNE MEDICATION MARKET, BY FORMULATION
11.3.3 EUROPE ACNE MEDICATION MARKET, BY TYPE
11.3.4 EUROPE ACNE MEDICATION MARKET, BY ACNE TYPE
11.3.5 EUROPE ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL
11.3.6 EUROPE ACNE MEDICATION MARKET, BY COUNTRY
11.3.6.1. GERMANY
11.3.6.1.1. GERMANY ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS
11.3.6.1.1.1. GERMANY RETINOIDS MARKET, BY THERAPEUTIC CLASS
11.3.6.1.1.2. GERMANY ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS
11.3.6.1.1.3. GERMANY OTHERS MARKET, BY THERAPEUTIC CLASS
11.3.6.1.2. GERMANY ACNE MEDICATION MARKET, BY FORMULATION
11.3.6.1.3. GERMANY ACNE MEDICATION MARKET, BY TYPE
11.3.6.1.4. GERMANY ACNE MEDICATION MARKET, BY ACNE TYPE
11.3.6.1.5. GERMANY ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL
11.3.6.2. FRANCE
11.3.6.2.1. FRANCE ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS
11.3.6.2.1.1. FRANCE RETINOIDS MARKET, BY THERAPEUTIC CLASS
11.3.6.2.1.2. FRANCE ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS
11.3.6.2.1.3. FRANCE OTHERS MARKET, BY THERAPEUTIC CLASS
11.3.6.2.2. FRANCE ACNE MEDICATION MARKET, BY FORMULATION
11.3.6.2.3. FRANCE ACNE MEDICATION MARKET, BY TYPE
11.3.6.2.4. FRANCE ACNE MEDICATION MARKET, BY ACNE TYPE
11.3.6.2.5. FRANCE ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL
11.3.6.3. UK
11.3.6.3.1. UK ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS
11.3.6.3.1.1. UK RETINOIDS MARKET, BY THERAPEUTIC CLASS
11.3.6.3.1.2. UK ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS
11.3.6.3.1.3. UK OTHERS MARKET, BY THERAPEUTIC CLASS
11.3.6.3.2. UK ACNE MEDICATION MARKET, BY FORMULATION
11.3.6.3.3. UK ACNE MEDICATION MARKET, BY TYPE
11.3.6.3.4. UK ACNE MEDICATION MARKET, BY ACNE TYPE
11.3.6.3.5. UK ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL
11.3.6.4. ITALY
11.3.6.4.1. ITALY ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS
11.3.6.4.1.1. ITALY RETINOIDS MARKET, BY THERAPEUTIC CLASS
11.3.6.4.1.2. ITALY ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS
11.3.6.4.1.3. ITALY OTHERS MARKET, BY THERAPEUTIC CLASS
11.3.6.4.2. ITALY ACNE MEDICATION MARKET, BY FORMULATION
11.3.6.4.3. ITALY ACNE MEDICATION MARKET, BY TYPE
11.3.6.4.4. ITALY ACNE MEDICATION MARKET, BY ACNE TYPE
11.3.6.4.5. ITALY ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL
11.3.6.5. SPAIN
11.3.6.5.1. SPAIN ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS
11.3.6.5.1.1. SPAIN RETINOIDS MARKET, BY THERAPEUTIC CLASS
11.3.6.5.1.2. SPAIN ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS
11.3.6.5.1.3. SPAIN OTHERS MARKET, BY THERAPEUTIC CLASS
11.3.6.5.2. SPAIN ACNE MEDICATION MARKET, BY FORMULATION
11.3.6.5.3. SPAIN ACNE MEDICATION MARKET, BY TYPE
11.3.6.5.4. SPAIN ACNE MEDICATION MARKET, BY ACNE TYPE
11.3.6.5.5. SPAIN ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL
11.3.6.6. REST OF EUROPE
11.3.6.6.1. REST OF EUROPE ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS
11.3.6.6.1.1. REST OF EUROPE RETINOIDS MARKET, BY THERAPEUTIC CLASS
11.3.6.6.1.2. REST OF EUROPE ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS
11.3.6.6.1.3. REST OF EUROPE OTHERS MARKET, BY THERAPEUTIC CLASS
11.3.6.6.2. REST OF EUROPE ACNE MEDICATION MARKET, BY FORMULATION
11.3.6.6.3. REST OF EUROPE ACNE MEDICATION MARKET, BY TYPE
11.3.6.6.4. REST OF EUROPE ACNE MEDICATION MARKET, BY ACNE TYPE
11.3.6.6.5. REST OF EUROPE ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL
11.4. ASIA-PACIFIC
11.4.1 ASIA-PACIFIC ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS
11.4.1.1. ASIA-PACIFIC RETINOIDS MARKET, BY THERAPEUTIC CLASS
11.4.1.2. ASIA-PACIFIC ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS
11.4.1.3. ASIA-PACIFIC OTHERS MARKET, BY THERAPEUTIC CLASS
11.4.2 ASIA-PACIFIC ACNE MEDICATION MARKET, BY FORMULATION
11.4.3 ASIA-PACIFIC ACNE MEDICATION MARKET, BY TYPE
11.4.4 ASIA-PACIFIC ACNE MEDICATION MARKET, BY ACNE TYPE
11.4.5 ASIA-PACIFIC ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL
11.4.6 ASIA-PACIFIC ACNE MEDICATION MARKET, BY COUNTRY
11.4.6.1. JAPAN
11.4.6.1.1. JAPAN ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS
11.4.6.1.1.1. JAPAN RETINOIDS MARKET, BY THERAPEUTIC CLASS
11.4.6.1.1.2. JAPAN ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS
11.4.6.1.1.3. JAPAN OTHERS MARKET, BY THERAPEUTIC CLASS
11.4.6.1.2. JAPAN ACNE MEDICATION MARKET, BY FORMULATION
11.4.6.1.3. JAPAN ACNE MEDICATION MARKET, BY TYPE
11.4.6.1.4. JAPAN ACNE MEDICATION MARKET, BY ACNE TYPE
11.4.6.1.5. JAPAN ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL
11.4.6.2. CHINA
11.4.6.2.1. CHINA ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS
11.4.6.2.1.1. CHINA RETINOIDS MARKET, BY THERAPEUTIC CLASS
11.4.6.2.1.2. CHINA ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS
11.4.6.2.1.3. CHINA OTHERS MARKET, BY THERAPEUTIC CLASS
11.4.6.2.2. CHINA ACNE MEDICATION MARKET, BY FORMULATION
11.4.6.2.3. CHINA ACNE MEDICATION MARKET, BY TYPE
11.4.6.2.4. CHINA ACNE MEDICATION MARKET, BY ACNE TYPE
11.4.6.2.5. CHINA ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL
11.4.6.3. INDIA
11.4.6.3.1. INDIA ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS
11.4.6.3.1.1. INDIA RETINOIDS MARKET, BY THERAPEUTIC CLASS
11.4.6.3.1.2. INDIA ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS
11.4.6.3.1.3. INDIA OTHERS MARKET, BY THERAPEUTIC CLASS
11.4.6.3.2. INDIA ACNE MEDICATION MARKET, BY FORMULATION
11.4.6.3.3. INDIA ACNE MEDICATION MARKET, BY TYPE
11.4.6.3.4. INDIA ACNE MEDICATION MARKET, BY ACNE TYPE
11.4.6.3.5. INDIA ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL
11.4.6.4. AUSTRALIA
11.4.6.4.1. AUSTRALIA ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS
11.4.6.4.1.1. AUSTRALIA RETINOIDS MARKET, BY THERAPEUTIC CLASS
11.4.6.4.1.2. AUSTRALIA ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS
11.4.6.4.1.3. AUSTRALIA OTHERS MARKET, BY THERAPEUTIC CLASS
11.4.6.4.2. AUSTRALIA ACNE MEDICATION MARKET, BY FORMULATION
11.4.6.4.3. AUSTRALIA ACNE MEDICATION MARKET, BY TYPE
11.4.6.4.4. AUSTRALIA ACNE MEDICATION MARKET, BY ACNE TYPE
11.4.6.4.5. AUSTRALIA ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL
11.4.6.5. SOUTH KOREA
11.4.6.5.1. SOUTH KOREA ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS
11.4.6.5.1.1. SOUTH KOREA RETINOIDS MARKET, BY THERAPEUTIC CLASS
11.4.6.5.1.2. SOUTH KOREA ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS
11.4.6.5.1.3. SOUTH KOREA OTHERS MARKET, BY THERAPEUTIC CLASS
11.4.6.5.2. SOUTH KOREA ACNE MEDICATION MARKET, BY FORMULATION
11.4.6.5.3. SOUTH KOREA ACNE MEDICATION MARKET, BY TYPE
11.4.6.5.4. SOUTH KOREA ACNE MEDICATION MARKET, BY ACNE TYPE
11.4.6.5.5. SOUTH KOREA ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL
11.4.6.6. REST OF ASIA-PACIFIC
11.4.6.6.1. REST OF ASIA-PACIFIC ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS
11.4.6.6.1.1. REST OF ASIA-PACIFIC RETINOIDS MARKET, BY THERAPEUTIC CLASS
11.4.6.6.1.2. REST OF ASIA-PACIFIC ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS
11.4.6.6.1.3. REST OF ASIA-PACIFIC OTHERS MARKET, BY THERAPEUTIC CLASS
11.4.6.6.2. REST OF ASIA-PACIFIC ACNE MEDICATION MARKET, BY FORMULATION
11.4.6.6.3. REST OF ASIA-PACIFIC ACNE MEDICATION MARKET, BY TYPE
11.4.6.6.4. REST OF ASIA-PACIFIC ACNE MEDICATION MARKET, BY ACNE TYPE
11.4.6.6.5. REST OF ASIA-PACIFIC ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL
11.5. REST OF WORLD
11.5.1 REST OF WORLD ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS
11.5.1.1. REST OF WORLD RETINOIDS MARKET, BY THERAPEUTIC CLASS
11.5.1.2. REST OF WORLD ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS
11.5.1.3. REST OF WORLD OTHERS MARKET, BY THERAPEUTIC CLASS
11.5.2 REST OF WORLD ACNE MEDICATION MARKET, BY FORMULATION
11.5.3 REST OF WORLD ACNE MEDICATION MARKET, BY TYPE
11.5.4 REST OF WORLD ACNE MEDICATION MARKET, BY ACNE TYPE
11.5.5 REST OF WORLD ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL
11.5.6 REST OF WORLD ACNE MEDICATION MARKET, BY COUNTRY
11.5.6.1. BRAZIL
11.5.6.1.1. BRAZIL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS
11.5.6.1.1.1. BRAZIL RETINOIDS MARKET, BY THERAPEUTIC CLASS
11.5.6.1.1.2. BRAZIL ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS
11.5.6.1.1.3. BRAZIL OTHERS MARKET, BY THERAPEUTIC CLASS
11.5.6.1.2. BRAZIL ACNE MEDICATION MARKET, BY FORMULATION
11.5.6.1.3. BRAZIL ACNE MEDICATION MARKET, BY TYPE
11.5.6.1.4. BRAZIL ACNE MEDICATION MARKET, BY ACNE TYPE
11.5.6.1.5. BRAZIL ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL
11.5.6.2. KINGDOM OF SAUDI ARABIA (KSA)
11.5.6.2.1. KINGDOM OF SAUDI ARABIA (KSA) ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS
11.5.6.2.1.1. KINGDOM OF SAUDI ARABIA (KSA) RETINOIDS MARKET, BY THERAPEUTIC CLASS
11.5.6.2.1.2. KINGDOM OF SAUDI ARABIA (KSA) ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS
11.5.6.2.1.3. KINGDOM OF SAUDI ARABIA (KSA) OTHERS MARKET, BY THERAPEUTIC CLASS
11.5.6.2.2. KINGDOM OF SAUDI ARABIA (KSA) ACNE MEDICATION MARKET, BY FORMULATION
11.5.6.2.3. KINGDOM OF SAUDI ARABIA (KSA) ACNE MEDICATION MARKET, BY TYPE
11.5.6.2.4. KINGDOM OF SAUDI ARABIA (KSA) ACNE MEDICATION MARKET, BY ACNE TYPE
11.5.6.2.5. KINGDOM OF SAUDI ARABIA (KSA) ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL
11.5.6.3. SOUTH AFRICA
11.5.6.3.1. SOUTH AFRICA ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS
11.5.6.3.1.1. SOUTH AFRICA RETINOIDS MARKET, BY THERAPEUTIC CLASS
11.5.6.3.1.2. SOUTH AFRICA ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS
11.5.6.3.1.3. SOUTH AFRICA OTHERS MARKET, BY THERAPEUTIC CLASS
11.5.6.3.2. SOUTH AFRICA ACNE MEDICATION MARKET, BY FORMULATION
11.5.6.3.3. SOUTH AFRICA ACNE MEDICATION MARKET, BY TYPE
11.5.6.3.4. SOUTH AFRICA ACNE MEDICATION MARKET, BY ACNE TYPE
11.5.6.3.5. SOUTH AFRICA ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL
11.5.6.4. REMAINING COUNTRIES
11.5.6.4.1. REMAINING COUNTRIES ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS
11.5.6.4.1.1. REMAINING COUNTRIES RETINOIDS MARKET, BY THERAPEUTIC CLASS
11.5.6.4.1.2. REMAINING COUNTRIES ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS
11.5.6.4.1.3. REMAINING COUNTRIES OTHERS MARKET, BY THERAPEUTIC CLASS
11.5.6.4.2. REMAINING COUNTRIES ACNE MEDICATION MARKET, BY FORMULATION
11.5.6.4.3. REMAINING COUNTRIES ACNE MEDICATION MARKET, BY TYPE
11.5.6.4.4. REMAINING COUNTRIES ACNE MEDICATION MARKET, BY ACNE TYPE
11.5.6.4.5. REMAINING COUNTRIES ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL
12. COMPANY PROFILES
12.1. PROCTER & GAMBLE
12.1.1 COMPANY OVERVIEW
12.1.2 COMPANY SNAPSHOT
12.1.3 OPERATING BUSINESS SEGMENTS
12.1.4 PRODUCT PORTFOLIO
12.1.5 BUSINESS PERFORMANCE
12.1.6 SALES BY BUSINESS SEGMENT
12.1.7 SALES BY GEOGRAPHIC SEGMENT
12.1.8 KEY STRATEGIC MOVES & DEVELOPMENTS
12.1.9 PRIMARY MARKET COMPETITORS
12.2. UNILEVER PLC
12.2.1 COMPANY OVERVIEW
12.2.2 COMPANY SNAPSHOT
12.2.3 OPERATING BUSINESS SEGMENTS
12.2.4 PRODUCT PORTFOLIO
12.2.5 BUSINESS PERFORMANCE
12.2.6 SALES BY BUSINESS SEGMENT
12.2.7 SALES BY GEOGRAPHIC SEGMENT
12.2.8 KEY STRATEGIC MOVES & DEVELOPMENTS
12.2.9 PRIMARY MARKET COMPETITORS
12.3. OBAGI MEDICAL
12.3.1 COMPANY OVERVIEW
12.3.2 COMPANY SNAPSHOT
12.3.3 PRODUCT PORTFOLIO
12.3.4 KEY STRATEGIC MOVES & DEVELOPMENTS
12.3.5 PRIMARY MARKET COMPETITORS
12.4. AVON PRODUCTS, INC.
12.4.1 COMPANY OVERVIEW
12.4.2 COMPANY SNAPSHOT
12.4.3 PRODUCT PORTFOLIO
12.4.4 KEY STRATEGIC MOVES & DEVELOPMENTS
12.4.5 PRIMARY MARKET COMPETITORS
12.5. HERBALIFE NUTRITION
12.5.1 COMPANY OVERVIEW
12.5.2 COMPANY SNAPSHOT
12.5.3 PRODUCT PORTFOLIO
12.5.4 BUSINESS PERFORMANCE
12.5.5 SALES BY GEOGRAPHIC SEGMENT
12.5.6 KEY STRATEGIC MOVES & DEVELOPMENTS
12.5.7 PRIMARY MARKET COMPETITORS
12.6. BEIERSDORF AG
12.6.1 COMPANY OVERVIEW
12.6.2 COMPANY SNAPSHOT
12.6.3 OPERATING BUSINESS SEGMENTS
12.6.4 PRODUCT PORTFOLIO
12.6.5 BUSINESS PERFORMANCE
12.6.6 SALES BY BUSINESS SEGMENT
12.6.7 SALES BY GEOGRAPHIC SEGMENT
12.6.8 KEY STRATEGIC MOVES & DEVELOPMENTS
12.6.9 PRIMARY MARKET COMPETITORS
12.7. ABBVIE INC
12.7.1 COMPANY OVERVIEW
12.7.2 COMPANY SNAPSHOT
12.7.3 OPERATING BUSINESS SEGMENTS
12.7.4 PRODUCT PORTFOLIO
12.7.5 BUSINESS PERFORMANCE
12.7.6 SALES BY BUSINESS SEGMENT
12.7.7 SALES BY GEOGRAPHIC SEGMENT
12.7.8 KEY STRATEGIC MOVES & DEVELOPMENTS
12.7.9 PRIMARY MARKET COMPETITORS
12.8. GALDERMA
12.8.1 COMPANY OVERVIEW
12.8.2 COMPANY SNAPSHOT
12.8.3 PRODUCT PORTFOLIO
12.8.4 KEY STRATEGIC MOVES & DEVELOPMENTS
12.8.5 PRIMARY MARKET COMPETITORS
12.9. ESTEE LAUDER INC.
12.9.1 COMPANY OVERVIEW
12.9.2 COMPANY SNAPSHOT
12.9.3 OPERATING BUSINESS SEGMENTS
12.9.4 PRODUCT PORTFOLIO
12.9.5 BUSINESS PERFORMANCE
12.9.6 SALES BY BUSINESS SEGMENT
12.9.7 SALES BY GEOGRAPHIC SEGMENT
12.9.8 KEY STRATEGIC MOVES & DEVELOPMENTS
12.9.9 PRIMARY MARKET COMPETITORS
12.10. GLAXOSMITHKLINE PLC
12.10.1 COMPANY OVERVIEW
12.10.2 COMPANY SNAPSHOT
12.10.3 OPERATING BUSINESS SEGMENTS
12.10.4 PRODUCT PORTFOLIO
12.10.5 BUSINESS PERFORMANCE
12.10.6 SALES BY BUSINESS SEGMENT
12.10.7 SALES BY GEOGRAPHIC SEGMENT
12.10.8 KEY STRATEGIC MOVES & DEVELOPMENTS
12.10.9 PRIMARY MARKET COMPETITORS
12.11. JOHNSON & JOHNSON
12.11.1 COMPANY OVERVIEW
12.11.2 COMPANY SNAPSHOT
12.11.3 OPERATING BUSINESS SEGMENTS
12.11.4 PRODUCT PORTFOLIO
12.11.5 BUSINESS PERFORMANCE
12.11.6 SALES BY BUSINESS SEGMENT
12.11.7 SALES BY GEOGRAPHIC SEGMENT
12.11.8 KEY STRATEGIC MOVES & DEVELOPMENTS
12.11.9 PRIMARY MARKET COMPETITORS
12.12. NEUTROGENA
12.12.1 COMPANY OVERVIEW
12.12.2 COMPANY SNAPSHOT
12.12.3 PRODUCT PORTFOLIO
12.12.4 KEY STRATEGIC MOVES & DEVELOPMENTS
12.12.5 PRIMARY MARKET COMPETITORS
12.13. HIMALAYA WELLNESS COMPANY
12.13.1 COMPANY OVERVIEW
12.13.2 COMPANY SNAPSHOT
12.13.3 PRODUCT PORTFOLIO
12.13.4 KEY STRATEGIC MOVES & DEVELOPMENTS
12.13.5 PRIMARY MARKET COMPETITORS
12.14. ALMIRALL S.A.
12.14.1 COMPANY OVERVIEW
12.14.2 COMPANY SNAPSHOT
12.14.3 OPERATING BUSINESS SEGMENTS
12.14.4 PRODUCT PORTFOLIO
12.14.5 BUSINESS PERFORMANCE
12.14.6 SALES BY GEOGRAPHIC SEGMENT
12.14.7 SALES BY GEOGRAPHIC SEGMENT
12.14.8 KEY STRATEGIC MOVES & DEVELOPMENTS
12.14.9 PRIMARY MARKET COMPETITORS
12.15. BAUSCH HEALTH COMPANIES INC.
12.15.1 COMPANY OVERVIEW
12.15.2 COMPANY SNAPSHOT
12.15.3 OPERATING BUSINESS SEGMENTS
12.15.4 PRODUCT PORTFOLIO
12.15.5 BUSINESS PERFORMANCE
12.15.6 SALES BY BUSINESS SEGMENT
12.15.7 SALES BY GEOGRAPHIC SEGMENT
12.15.8 KEY STRATEGIC MOVES & DEVELOPMENTS
12.15.9 PRIMARY MARKET COMPETITORS
12.16. AMWAY CORP.
12.16.1 COMPANY OVERVIEW
12.16.2 COMPANY SNAPSHOT
12.16.3 RODUCT PORTFOLIO
12.16.4 KEY STRATEGIC MOVES & DEVELOPMENTS
12.16.5 PRIMARY MARKET COMPETITORS
12.17. ABBOTT LABORATORIES
12.17.1 COMPANY OVERVIEW
12.17.2 COMPANY SNAPSHOT
12.17.3 OPERATING BUSINESS SEGMENTS
12.17.4 PRODUCT PORTFOLIO
12.17.5 BUSINESS PERFORMANCE
12.17.6 SALES BY BUSINESS SEGMENT
12.17.7 SALES BY GEOGRAPHIC SEGMENT
12.17.8 KEY STRATEGIC MOVES & DEVELOPMENTS
12.17.9 PRIMARY MARKET COMPETITORS
12.18. TEVA PHARMACEUTICALS
12.18.1 COMPANY OVERVIEW
12.18.2 COMPANY SNAPSHOT
12.18.3 PRODUCT PORTFOLIO
12.18.4 BUSINESS PERFORMANCE
12.18.5 SALES BY GEOGRAPHIC SEGMENT
12.18.6 KEY STRATEGIC MOVES & DEVELOPMENTS
12.18.7 PRIMARY MARKET COMPETITORS
12.19. SUN PHARMA
12.19.1 COMPANY OVERVIEW
12.19.2 COMPANY SNAPSHOT
12.19.3 PRODUCT PORTFOLIO
12.19.4 BUSINESS PERFORMANCE
12.19.5 SALES BY GEOGRAPHIC SEGMENT
12.19.6 KEY STRATEGIC MOVES & DEVELOPMENTS
12.19.7 PRIMARY MARKET COMPETITORS
12.20. GLENMARK PHARMACEUTICALS
12.20.1 COMPANY OVERVIEW
12.20.2 COMPANY SNAPSHOT
12.20.3 PRODUCT PORTFOLIO
12.20.4 BUSINESS PERFORMANCE
12.20.5 SALES BY GEOGRAPHIC SEGMENT
12.20.6 KEY STRATEGIC MOVES & DEVELOPMENTS
12.20.7 PRIMARY MARKET COMPETITORS
12.21. VIATRIS
12.21.1 COMPANY OVERVIEW
12.21.2 COMPANY SNAPSHOT
12.21.3 OPERATING BUSINESS SEGMENTS
12.21.4 PRODUCT PORTFOLIO
12.21.5 BUSINESS PERFORMANCE
12.21.6 SALES BY GEOGRAPHIC SEGMENT
12.21.7 KEY STRATEGIC MOVES & DEVELOPMENTS
12.21.8 PRIMARY MARKET COMPETITORS
12.22. PFIZER INC.
12.22.1 COMPANY SNAPSHOT
12.22.2 COMPANY SNAPSHOT
12.22.3 OPERATING BUSINESS SEGMENTS
12.22.4 PRODUCT PORTFOLIO
12.22.5 BUSINESS PERFORMANCE
12.22.6 SALES BY GEOGRAPHIC SEGMENT
12.22.7 SALES BY GEOGRAPHIC SEGMENT
12.22.8 KEY STRATEGIC MOVES & DEVELOPMENTS
12.22.9 PRIMARY MARKET COMPETITORS
12.23. MAYNE PHARMA GROUP LIMITED
12.23.1 COMPANY OVERVIEW
12.23.2 COMPANY SNAPSHOT
12.23.3 OPERATING BUSINESS SEGMENTS
12.23.4 PRODUCT PORTFOLIO
12.23.5 BUSINESS PERFORMANCE
12.23.6 SALES BY BUSINESS SEGMENT
12.23.7 SALES BY GEOGRAPHIC SEGMENT
12.23.8 KEY STRATEGIC MOVES & DEVELOPMENTS
12.23.9 PRIMARY MARKET COMPETITORS
12.24. CLINIQUE LABORATORIES
12.24.1 COMPANY OVERVIEW
12.24.2 COMPANY SNAPSHOT
12.24.3 PRODUCT PORTFOLIO
12.24.4 KEY STRATEGIC MOVES & DEVELOPMENTS
12.24.5 PRIMARY MARKET COMPETITORS
12.25. COLGATE-PALMOLIVE COMPANY
12.25.1 COMPANY OVERVIEW
12.25.2 COMPANY SNAPSHOT
12.25.3 OPERATING BUSINESS SEGMENTS
12.25.4 PRODUCT PORTFOLIO
12.25.5 BUSINESS PERFORMANCE
12.25.6 SALES BY BUSINESS SEGMENT
12.25.7 SALES BY GEOGRAPHIC SEGMENT
12.25.8 KEY STRATEGIC MOVES & DEVELOPMENTS
12.25.9 PRIMARY MARKET COMPETITORS
12.26. L’OREAL
12.26.1 COMPANY OVERVIEW
12.26.2 COMPANY SNAPSHOT
12.26.3 OPERATING BUSINESS SEGMENTS
12.26.4 PRODUCT PORTFOLIO
12.26.5 BUSINESS PERFORMANCE
12.26.6 SALES BY BUSINESS SEGMENT
12.26.7 SALES BY GEOGRAPHIC SEGMENT
12.26.8 KEY STRATEGIC MOVES & DEVELOPMENTS
12.26.9 PRIMARY MARKET COMPETITORS
LIST OF TABLES
TABLE 1. GLOBAL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 2. GLOBAL RETINOIDS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 3. TOPICAL RETINOID & COMBINATION RETIONOID MARKET, BY REGION, 2021-2030, MILLION USD
TABLE 4. ORAL RETINOID (ISORETINION) MARKET, BY REGION, 2021-2030, MILLION USD
TABLE 5. RETINOIDS MARKET, BY REGION, 2021-2030, MILLION USD
TABLE 6. GLOBAL ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 7. TOPICAL ANTIBIOTIC & COMBINATION ANTIBIOTICS MARKET, BY REGION, 2021-2030, MILLION USD
TABLE 8. ORAL ANTIBIOTIC MARKET, BY REGION, 2021-2030, MILLION USD
TABLE 9. ANTIBIOTICS MARKET, BY REGION, 2021-2030, MILLION USD
TABLE 10. SALICYLIC ACID MARKET, BY REGION, 2021-2030, MILLION USD
TABLE 11. BENZOYL PEROXIDE MARKET, BY REGION, 2021-2030, MILLION USD
TABLE 12. GLOBAL OTHERS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 13. OTHER TOPICALS (AZELAIC ACID) MARKET, BY REGION, 2021-2030, MILLION USD
TABLE 14. OTHERS OTC MARKET, BY REGION, 2021-2030, MILLION USD
TABLE 15. OTHERS MARKET, BY REGION, 2021-2030, MILLION USD
TABLE 16. GLOBAL ACNE MEDICATION MARKET, BY FORMULATION, 2021-2030, MILLION USD
TABLE 17. TOPICAL MEDICATIONS MARKET, BY REGION, 2021-2030, MILLION USD
TABLE 18. ORAL MEDICATIONS MARKET, BY REGION, 2021-2030, MILLION USD
TABLE 19. GLOBAL ACNE MEDICATION MARKET, BY TYPE, 2021-2030, MILLION USD
TABLE 20. PRESCRIPTION MEDICINES MARKET, BY REGION, 2021-2030, MILLION USD
TABLE 21. OVER-THE-COUNTER (OTC )MEDICINES MARKET, BY REGION, 2021-2030, MILLION USD
TABLE 22. GLOBAL ACNE MEDICATION MARKET, BY ACNE TYPE, 2021-2030, MILLION USD
TABLE 23. INFLAMMATORY ACNE MARKET, BY REGION, 2021-2030, MILLION USD
TABLE 24. NON-INFLAMMATORY ACNE MARKET, BY REGION, 2021-2030, MILLION USD
TABLE 25. GLOBAL ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030, MILLION USD
TABLE 26. GROCERY SHOPS MARKET, BY REGION, 2021-2030, MILLION USD
TABLE 27. PHARMACIES & DRUG STORES MARKET, BY REGION, 2021-2030, MILLION USD
TABLE 28. E-COMMERCE MARKET, BY REGION, 2021-2030, MILLION USD
TABLE 29. GLOBAL ACNE MEDICATION MARKET, BY REGION, 2021-2030, MILLION USD
TABLE 30. NORTH AMERICA ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 31. NORTH AMERICA RETINOIDS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 32. NORTH AMERICA ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 33. NORTH AMERICA OTHERS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 34. NORTH AMERICA ACNE MEDICATION MARKET, BY FORMULATION, 2021-2030, MILLION USD
TABLE 35. NORTH AMERICA ACNE MEDICATION MARKET, BY TYPE, 2021-2030, MILLION USD
TABLE 36. NORTH AMERICA ACNE MEDICATION MARKET, BY ACNE TYPE, 2021-2030, MILLION USD
TABLE 37. NORTH AMERICA ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030, MILLION USD
TABLE 38. NORTH AMERICA ACNE MEDICATION MARKET, BY COUNTRY, 2021-2030, MILLION USD
TABLE 39. U.S. ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 40. U.S. RETINOIDS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 41. U.S. ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 42. U.S. OTHERS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 43. U.S. ACNE MEDICATION MARKET, BY FORMULATION, 2021-2030, MILLION USD
TABLE 44. U.S. ACNE MEDICATION MARKET, BY TYPE, 2021-2030, MILLION USD
TABLE 45. U.S. ACNE MEDICATION MARKET, BY ACNE TYPE, 2021-2030, MILLION USD
TABLE 46. U.S. ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030, MILLION USD
TABLE 47. CANADA ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 48. CANADA RETINOIDS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 49. CANADA ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 50. CANADA OTHERS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 51. CANADA ACNE MEDICATION MARKET, BY FORMULATION, 2021-2030, MILLION USD
TABLE 52. CANADA ACNE MEDICATION MARKET, BY TYPE, 2021-2030, MILLION USD
TABLE 53. CANADA ACNE MEDICATION MARKET, BY ACNE TYPE, 2021-2030, MILLION USD
TABLE 54. CANADA ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030, MILLION USD
TABLE 55. MEXICO ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 56. MEXICO RETINOIDS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 57. MEXICO ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 58. MEXICO OTHERS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 59. MEXICO ACNE MEDICATION MARKET, BY FORMULATION, 2021-2030, MILLION USD
TABLE 60. MEXICO ACNE MEDICATION MARKET, BY TYPE, 2021-2030, MILLION USD
TABLE 61. MEXICO ACNE MEDICATION MARKET, BY ACNE TYPE, 2021-2030, MILLION USD
TABLE 62. MEXICO ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030, MILLION USD
TABLE 63. EUROPE ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 64. EUROPE RETINOIDS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 65. EUROPE ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 66. EUROPE OTHERS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 67. EUROPE ACNE MEDICATION MARKET, BY FORMULATION, 2021-2030, MILLION USD
TABLE 68. EUROPE ACNE MEDICATION MARKET, BY TYPE, 2021-2030, MILLION USD
TABLE 69. EUROPE ACNE MEDICATION MARKET, BY ACNE TYPE, 2021-2030, MILLION USD
TABLE 70. EUROPE ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030, MILLION USD
TABLE 71. EUROPE ACNE MEDICATION MARKET, BY COUNTRY, 2021-2030, MILLION USD
TABLE 72. GERMANY ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 73. GERMANY RETINOIDS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 74. GERMANY ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 75. GERMANY OTHERS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 76. GERMANY ACNE MEDICATION MARKET, BY FORMULATION, 2021-2030, MILLION USD
TABLE 77. GERMANY ACNE MEDICATION MARKET, BY TYPE, 2021-2030, MILLION USD
TABLE 78. GERMANY ACNE MEDICATION MARKET, BY ACNE TYPE, 2021-2030, MILLION USD
TABLE 79. GERMANY ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030, MILLION USD
TABLE 80. FRANCE ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 81. FRANCE RETINOIDS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 82. FRANCE ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 83. FRANCE OTHERS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 84. FRANCE ACNE MEDICATION MARKET, BY FORMULATION, 2021-2030, MILLION USD
TABLE 85. FRANCE ACNE MEDICATION MARKET, BY TYPE, 2021-2030, MILLION USD
TABLE 86. FRANCE ACNE MEDICATION MARKET, BY ACNE TYPE, 2021-2030, MILLION USD
TABLE 87. FRANCE ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030, MILLION USD
TABLE 88. UK ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 89. UK RETINOIDS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 90. UK ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 91. UK OTHERS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 92. UK ACNE MEDICATION MARKET, BY FORMULATION, 2021-2030, MILLION USD
TABLE 93. UK ACNE MEDICATION MARKET, BY TYPE, 2021-2030, MILLION USD
TABLE 94. UK ACNE MEDICATION MARKET, BY ACNE TYPE, 2021-2030, MILLION USD
TABLE 95. UK ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030, MILLION USD
TABLE 96. ITALY ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 97. ITALY RETINOIDS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 98. ITALY ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 99. ITALY OTHERS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 100. ITALY ACNE MEDICATION MARKET, BY FORMULATION, 2021-2030, MILLION USD
TABLE 101. ITALY ACNE MEDICATION MARKET, BY TYPE, 2021-2030, MILLION USD
TABLE 102. ITALY ACNE MEDICATION MARKET, BY ACNE TYPE, 2021-2030, MILLION USD
TABLE 103. ITALY ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030, MILLION USD
TABLE 104. SPAIN ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 105. SPAIN RETINOIDS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 106. SPAIN ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 107. SPAIN OTHERS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 108. SPAIN ACNE MEDICATION MARKET, BY FORMULATION, 2021-2030, MILLION USD
TABLE 109. SPAIN ACNE MEDICATION MARKET, BY TYPE, 2021-2030, MILLION USD
TABLE 110. SPAIN ACNE MEDICATION MARKET, BY ACNE TYPE, 2021-2030, MILLION USD
TABLE 111. SPAIN ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030, MILLION USD
TABLE 112. REST OF EUROPE ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 113. REST OF EUROPE RETINOIDS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 114. REST OF EUROPE ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 115. REST OF EUROPE OTHERS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 116. REST OF EUROPE ACNE MEDICATION MARKET, BY FORMULATION, 2021-2030, MILLION USD
TABLE 117. REST OF EUROPE ACNE MEDICATION MARKET, BY TYPE, 2021-2030, MILLION USD
TABLE 118. REST OF EUROPE ACNE MEDICATION MARKET, BY ACNE TYPE, 2021-2030, MILLION USD
TABLE 119. REST OF EUROPE ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030, MILLION USD
TABLE 120. ASIA-PACIFIC ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 121. ASIA-PACIFIC RETINOIDS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 122. ASIA-PACIFIC ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 123. ASIA-PACIFIC OTHERS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 124. ASIA-PACIFIC ACNE MEDICATION MARKET, BY FORMULATION, 2021-2030, MILLION USD
TABLE 125. ASIA-PACIFIC ACNE MEDICATION MARKET, BY TYPE, 2021-2030, MILLION USD
TABLE 126. ASIA-PACIFIC ACNE MEDICATION MARKET, BY ACNE TYPE, 2021-2030, MILLION USD
TABLE 127. ASIA-PACIFIC ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030, MILLION USD
TABLE 128. ASIA-PACIFIC ACNE MEDICATION MARKET, BY COUNTRY, 2021-2030, MILLION USD
TABLE 129. JAPAN ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 130. JAPAN RETINOIDS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 131. JAPAN ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 132. JAPAN OTHERS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 133. JAPAN ACNE MEDICATION MARKET, BY FORMULATION, 2021-2030, MILLION USD
TABLE 134. JAPAN ACNE MEDICATION MARKET, BY TYPE, 2021-2030, MILLION USD
TABLE 135. JAPAN ACNE MEDICATION MARKET, BY ACNE TYPE, 2021-2030, MILLION USD
TABLE 136. JAPAN ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030, MILLION USD
TABLE 137. CHINA ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 138. CHINA RETINOIDS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 139. CHINA ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 140. CHINA OTHERS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 141. CHINA ACNE MEDICATION MARKET, BY FORMULATION, 2021-2030, MILLION USD
TABLE 142. CHINA ACNE MEDICATION MARKET, BY TYPE, 2021-2030, MILLION USD
TABLE 143. CHINA ACNE MEDICATION MARKET, BY ACNE TYPE, 2021-2030, MILLION USD
TABLE 144. CHINA ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030, MILLION USD
TABLE 145. INDIA ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 146. INDIA RETINOIDS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 147. INDIA ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 148. INDIA OTHERS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 149. INDIA ACNE MEDICATION MARKET, BY FORMULATION, 2021-2030, MILLION USD
TABLE 150. INDIA ACNE MEDICATION MARKET, BY TYPE, 2021-2030, MILLION USD
TABLE 151. INDIA ACNE MEDICATION MARKET, BY ACNE TYPE, 2021-2030, MILLION USD
TABLE 152. INDIA ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030, MILLION USD
TABLE 153. AUSTRALIA ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 154. AUSTRALIA RETINOIDS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 155. AUSTRALIA ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 156. AUSTRALIA OTHERS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 157. AUSTRALIA ACNE MEDICATION MARKET, BY FORMULATION, 2021-2030, MILLION USD
TABLE 158. AUSTRALIA ACNE MEDICATION MARKET, BY TYPE, 2021-2030, MILLION USD
TABLE 159. AUSTRALIA ACNE MEDICATION MARKET, BY ACNE TYPE, 2021-2030, MILLION USD
TABLE 160. AUSTRALIA ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030, MILLION USD
TABLE 161. SOUTH KOREA ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 162. SOUTH KOREA RETINOIDS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 163. SOUTH KOREA ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 164. SOUTH KOREA OTHERS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 165. SOUTH KOREA ACNE MEDICATION MARKET, BY FORMULATION, 2021-2030, MILLION USD
TABLE 166. SOUTH KOREA ACNE MEDICATION MARKET, BY TYPE, 2021-2030, MILLION USD
TABLE 167. SOUTH KOREA ACNE MEDICATION MARKET, BY ACNE TYPE, 2021-2030, MILLION USD
TABLE 168. SOUTH KOREA ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030, MILLION USD
TABLE 169. REST OF ASIA-PACIFIC ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 170. REST OF ASIA-PACIFIC RETINOIDS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 171. REST OF ASIA-PACIFIC ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 172. REST OF ASIA-PACIFIC OTHERS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 173. REST OF ASIA-PACIFIC ACNE MEDICATION MARKET, BY FORMULATION, 2021-2030, MILLION USD
TABLE 174. REST OF ASIA-PACIFIC ACNE MEDICATION MARKET, BY TYPE, 2021-2030, MILLION USD
TABLE 175. REST OF ASIA-PACIFIC ACNE MEDICATION MARKET, BY ACNE TYPE, 2021-2030, MILLION USD
TABLE 176. REST OF ASIA-PACIFIC ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030, MILLION USD
TABLE 177. REST OF WORLD ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 178. REST OF WORLD RETINOIDS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 179. REST OF WORLD ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 180. REST OF WORLD OTHERS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 181. REST OF WORLD ACNE MEDICATION MARKET, BY FORMULATION, 2021-2030, MILLION USD
TABLE 182. REST OF WORLD ACNE MEDICATION MARKET, BY TYPE, 2021-2030, MILLION USD
TABLE 183. REST OF WORLD ACNE MEDICATION MARKET, BY ACNE TYPE, 2021-2030, MILLION USD
TABLE 184. REST OF WORLD ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030, MILLION USD
TABLE 185. REST OF WORLD ACNE MEDICATION MARKET, BY COUNTRY, 2021-2030, MILLION USD
TABLE 186. BRAZIL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 187. BRAZIL RETINOIDS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 188. BRAZIL ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 189. BRAZIL OTHERS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 190. BRAZIL ACNE MEDICATION MARKET, BY FORMULATION, 2021-2030, MILLION USD
TABLE 191. BRAZIL ACNE MEDICATION MARKET, BY TYPE, 2021-2030, MILLION USD
TABLE 192. BRAZIL ACNE MEDICATION MARKET, BY ACNE TYPE, 2021-2030, MILLION USD
TABLE 193. BRAZIL ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030, MILLION USD
TABLE 194. KINGDOM OF SAUDI ARABIA (KSA) ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 195. KINGDOM OF SAUDI ARABIA (KSA) RETINOIDS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 196. KINGDOM OF SAUDI ARABIA (KSA) ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 197. KINGDOM OF SAUDI ARABIA (KSA) OTHERS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 198. KINGDOM OF SAUDI ARABIA (KSA) ACNE MEDICATION MARKET, BY FORMULATION, 2021-2030, MILLION USD
TABLE 199. KINGDOM OF SAUDI ARABIA (KSA) ACNE MEDICATION MARKET, BY TYPE, 2021-2030, MILLION USD
TABLE 200. KINGDOM OF SAUDI ARABIA (KSA) ACNE MEDICATION MARKET, BY ACNE TYPE, 2021-2030, MILLION USD
TABLE 201. KINGDOM OF SAUDI ARABIA (KSA) ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030, MILLION USD
TABLE 202. SOUTH AFRICA ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 203. SOUTH AFRICA RETINOIDS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 204. SOUTH AFRICA ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 205. SOUTH AFRICA OTHERS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 206. SOUTH AFRICA ACNE MEDICATION MARKET, BY FORMULATION, 2021-2030, MILLION USD
TABLE 207. SOUTH AFRICA ACNE MEDICATION MARKET, BY TYPE, 2021-2030, MILLION USD
TABLE 208. SOUTH AFRICA ACNE MEDICATION MARKET, BY ACNE TYPE, 2021-2030, MILLION USD
TABLE 209. SOUTH AFRICA ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030, MILLION USD
TABLE 210. REMAINING COUNTRIES ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 211. REMAINING COUNTRIES RETINOIDS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 212. REMAINING COUNTRIES ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 213. REMAINING COUNTRIES OTHERS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
TABLE 214. REMAINING COUNTRIES ACNE MEDICATION MARKET, BY FORMULATION, 2021-2030, MILLION USD
TABLE 215. REMAINING COUNTRIES ACNE MEDICATION MARKET, BY TYPE, 2021-2030, MILLION USD
TABLE 216. REMAINING COUNTRIES ACNE MEDICATION MARKET, BY ACNE TYPE, 2021-2030, MILLION USD
TABLE 217. REMAINING COUNTRIES ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030, MILLION USD
TABLE 218. PROCTER & GAMBLE: COMPANY SNAPSHOT
TABLE 219. PROCTER & GAMBLE: OPERATING SEGMENTS
TABLE 220. PROCTER & GAMBLE: PRODUCT PORTFOLIO
TABLE 221. PROCTER & GAMBLE: BUSINESS SEGMENT
TABLE 222. PROCTER & GAMBLE: GEOGRAPHIC SEGMENT
TABLE 223. PROCTER & GAMBLE: KEY STRATEGIC MOVES & DEVELOPMENTS
TABLE 224. UNILEVER PLC: COMPANY SNAPSHOT
TABLE 225. UNILEVER PLC: OPERATING SEGMENTS
TABLE 226. UNILEVER PLC: PRODUCT PORTFOLIO
TABLE 227. UNILEVER PLC: BUSINESS SEGMENT
TABLE 228. UNILEVER PLC: GEOGRAPHIC SEGMENT
TABLE 229. UNILEVER PLC: KEY STRATEGIC MOVES & DEVELOPMENTS
TABLE 230. OBAGI MEDICAL: COMPANY SNAPSHOT
TABLE 231. OBAGI MEDICAL: PRODUCT PORTFOLIO
TABLE 232. OBAGI MEDICAL: KEY STRATEGIC MOVES & DEVELOPMENTS
TABLE 233. AVON PRODUCTS, INC.: COMPANY SNAPSHOT
TABLE 234. AVON PRODUCTS, INC: PRODUCT PORTFOLIO
TABLE 235. AVON PRODUCTS, INC: KEY STRATEGIC MOVES & DEVELOPMENTS
TABLE 236. HERBALIFE NUTRITION: COMPANY SNAPSHOT
TABLE 237. HERBALIFE NUTRITION: PRODUCT PORTFOLIO
TABLE 238. HERBALIFE NUTRITION: GEOGRAPHIC SEGMENT
TABLE 239. HERBALIFE NUTRITION: KEY STRATEGIC MOVES & DEVELOPMENTS
TABLE 240. BEIERSDORF AG: COMPANY SNAPSHOT
TABLE 241. BEIERSDORF AG: OPERATING SEGMENTS
TABLE 242. BEIERSDORF AG: PRODUCT PORTFOLIO
TABLE 243. BEIERSDORF AG: BUSINESS SEGMENT
TABLE 244. BEIERSDORF AG: GEOGRAPHIC SEGMENT
TABLE 245. BEIERSDORF AG: KEY STRATEGIC MOVES & DEVELOPMENTS
TABLE 246. ABBVIE INC: COMPANY SNAPSHOT
TABLE 247. ABBVIE INC: OPERATING SEGMENTS
TABLE 248. ABBVIE INC: PRODUCT PORTFOLIO
TABLE 249. ABBVIE INC: NET SALES, 2019–2021 ($MILLION)
TABLE 250. ABBVIE INC: BUSINESS SEGMENT
TABLE 251. ABBVIE INC: GEOGRAPHIC SEGMENT
TABLE 252. ABBVIE INC: KEY STRATEGIC MOVES & DEVELOPMENTS
TABLE 253. GALDERMA: COMPANY SNAPSHOT
TABLE 254. GALDERMA.: PRODUCT PORTFOLIO
TABLE 255. GALDERMA.: KEY STRATEGIC MOVES & DEVELOPMENTS
TABLE 256. ESTEE LAUDER INC.: COMPANY SNAPSHOT
TABLE 257. ESTEE LAUDER INC.: OPERATING SEGMENTS
TABLE 258. ESTEE LAUDER INC.: PRODUCT PORTFOLIO
TABLE 259. ESTEE LAUDER INC.: BUSINESS SEGMENT
TABLE 260. ESTEE LAUDER INC.: GEOGRAPHIC SEGMENT
TABLE 261. ESTEE LAUDER INC.: KEY STRATEGIC MOVES & DEVELOPMENTS
TABLE 262. GLAXOSMITHKLINE PLC: COMPANY SNAPSHOT
TABLE 263. GLAXOSMITHKLINE PLC: OPERATING SEGMENTS
TABLE 264. GLAXOSMITHKLINE PLC: PRODUCT PORTFOLIO
TABLE 265. GLAXOSMITHKLINE PLC: BUSINESS SEGMENT
TABLE 266. GLAXOSMITHKLINE PLC: GEOGRAPHIC SEGMENT
TABLE 267. GLAXOSMITHKLINE PLC: KEY STRATEGIC MOVES & DEVELOPMENT
TABLE 268. JOHNSON & JOHNSON: COMPANY SNAPSHOT
TABLE 269. JOHNSON & JOHNSON: OPERATING SEGMENTS
TABLE 270. JOHNSON & JOHNSON: PRODUCT PORTFOLIO
TABLE 271. JOHNSON & JOHNSON: BUSINESS SEGMENT
TABLE 272. JOHNSON & JOHNSON: GEOGRAPHIC SEGMENT
TABLE 273. JOHNSON & JOHNSON: KEY STRATEGIC MOVES & DEVELOPMENTS
TABLE 274. NEUTROGENA: COMPANY SNAPSHOT
TABLE 275. NEUTROGENA: PRODUCT PORTFOLIO
TABLE 276. NEUTROGENA: KEY STRATEGIC MOVES & DEVELOPMENTS
TABLE 277. HIMALAYA WELLNESS COMPANY: COMPANY SNAPSHOT
TABLE 278. HIMALAYA WELLNESS COMPANY: PRODUCT PORTFOLIO
TABLE 279. HIMALAYA WELLNESS COMPANY: KEY STRATEGIC MOVES & DEVELOPMENTS
TABLE 280. ALMIRALL S.A.: COMPANY SNAPSHOT
TABLE 281. ALMIRALL S.A.: OPERATING SEGMENTS
TABLE 282. ALMIRALL S.A.: PRODUCT PORTFOLIO
TABLE 283. ALMIRALL S.A.: BUSINESS SEGMENT
TABLE 284. ALMIRALL S.A.: GEOGRAPHIC SEGMENT
TABLE 285. BAUSCH HEALTH COMPANIES INC.: COMPANY SNAPSHOT
TABLE 286. BAUSCH HEALTH COMPANIES INC.: OPERATING SEGMENTS
TABLE 287. BAUSCH HEALTH COMPANIES INC.: PRODUCT PORTFOLIO
TABLE 288. BAUSCH HEALTH COMPANIES INC.: BUSINESS SEGMENT
TABLE 289. BAUSCH HEALTH COMPANIES INC.: GEOGRAPHIC SEGMENT
TABLE 290. BAUSCH HEALTH COMPANIES INC.: KEY STRATEGIC MOVES & DEVELOPMENTS
TABLE 291. AMWAY CORP.: COMPANY SNAPSHOT
TABLE 292. AMWAY CORP.: PRODUCT PORTFOLIO
TABLE 293. AMWAY CORP.: KEY STRATEGIC MOVES & DEVELOPMENT
TABLE 294. ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 295. ABBOTT LABORATORIES: BUSINESS SEGMENTS
TABLE 296. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 297. ABBOTT LABORATORIES: BUSINESS SEGMENT
TABLE 298. ABBOTT LABORATORIES: GEOGRAPHIC SEGMENT
TABLE 299. ABBOTT LABORATORIES: KEY STRATEGIC MOVES & DEVELOPMENT
TABLE 300. TEVA PHARMACEUTICALS: COMPANY SNAPSHOT
TABLE 301. TEVA PHARMACEUTICAL: PRODUCT PORTFOLIO
TABLE 302. TEVA PHARMACEUTICAL: GEOGRAPHIC SEGMENT
TABLE 303. TEVA PHARMACEUTICALS: KEY STRATEGIC MOVES & DEVELOPMENTS
TABLE 304. SUN PHARMA: COMPANY SNAPSHOT
TABLE 305. SUN PHARMA: PRODUCT PORTFOLIO
TABLE 306. SUN PHARMA: GEOGRAPHIC SEGMENT
TABLE 307. SUN PHARMA: KEY STRATEGIC MOVES & DEVELOPMENTS
TABLE 308. GLENMARK PHARMACEUTICALS: COMPANY SNAPSHOT
TABLE 309. GLENMARK PHARMACEUTICALS: PRODUCT PORTFOLIO
TABLE 310. GLENMARK PHARMACEUTICALS: GEOGRAPHIC SEGMENT
TABLE 311. GLENMARK PHARMACEUTICALS: KEY STRATEGIC MOVES & DEVELOPMENTS
TABLE 312. VIATRIS: COMPANY SNAPSHOT
TABLE 313. VIATRIS: OPERATING SEGMENTS
TABLE 314. VIATRIS: PRODUCT PORTFOLIO
TABLE 315. VIATRIS: GEOGRAPHIC SEGMENT
TABLE 316. PFIZER INC.: COMPANY SNAPSHOT
TABLE 317. PFIZER INC.: OPERATING SEGMENTS
TABLE 318. PFIZER INC.: PRODUCT PORTFOLIO
TABLE 319. PFIZER INC.: BUSINESS SEGMENT
TABLE 320. PFIZER INC.: GEOGRAPHIC SEGMENT
TABLE 321. MAYNE PHARMA GROUP LIMITED: COMPANY SNAPSHOT
TABLE 322. MAYNE PHARMA GROUP LIMITED: OPERATING SEGMENTS
TABLE 323. MAYNE PHARMA GROUP LIMITED: PRODUCT PORTFOLIO
TABLE 324. MAYNE PHARMA GROUP LIMITED: BUSINESS SEGMENT
TABLE 325. MAYNE PHARMA GROUP LIMITED: GEOGRAPHIC SEGMENT
TABLE 326. MAYNE PHARMA GROUP LIMITED: KEY STRATEGIC MOVES & DEVELOPMENTS
TABLE 327. CLINIQUE LABORATORIES: COMPANY SNAPSHOT
TABLE 328. CLINIQUE LABORATORIES: PRODUCT PORTFOLIO
TABLE 329. CLINIQUE LABORATORIES: KEY STRATEGIC MOVES & DEVELOPMENTS
TABLE 330. COLGATE-PALMOLIVE: COMPANY SNAPSHOT
TABLE 331. COLGATE-PALMOLIVE: OPERATING SEGMENTS
TABLE 332. COLGATE-PALMOLIVE: PRODUCT PORTFOLIO
TABLE 333. COLGATE-PALMOLIVE: BUSINESS SEGMENT
TABLE 334. COLGATE-PALMOLIVE: GEOGRAPHIC SEGMENT
TABLE 335. COLGATE-PALMOLIVE: KEY STRATEGIC MOVES & DEVELOPMENTS
TABLE 336. L’OREAL: COMPANY SNAPSHOT
TABLE 337. L’OREAL: OPERATING SEGMENTS
TABLE 338. L’OREAL: PRODUCT PORTFOLIO
TABLE 339. L’OREAL: BUSINESS SEGMENT
TABLE 340. L’OREAL: GEOGRAPHIC SEGMENT
TABLE 341. L’OREAL: KEY STRATEGIC MOVES & DEVELOPMENTS
LIST OF FIGURES
FIGURE 1. MARKET SHARE ANALYSIS OF TOP ACNE MEDICATION PROVIDERS, 2022
FIGURE 2. GLOBAL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 3. GLOBAL RETINOIDS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 4. TOPICAL RETINOID & COMBINATION RETIONOID MARKET, BY REGION, 2021-2030, MILLION USD
FIGURE 5. ORAL RETINOID (ISORETINION) MARKET, BY REGION, 2021-2030, MILLION USD
FIGURE 6. RETINOIDS MARKET, BY REGION, 2021-2030, MILLION USD
FIGURE 7. GLOBAL ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 8. TOPICAL ANTIBIOTIC & COMBINATION ANTIBIOTICS MARKET, BY REGION, 2021-2030, MILLION USD
FIGURE 9. ORAL ANTIBIOTIC MARKET, BY REGION, 2021-2030, MILLION USD
FIGURE 10. ANTIBIOTICS MARKET, BY REGION, 2021-2030, MILLION USD
FIGURE 11. SALICYLIC ACID MARKET, BY REGION, 2021-2030, MILLION USD
FIGURE 12. BENZOYL PEROXIDE MARKET, BY REGION, 2021-2030, MILLION USD
FIGURE 13. GLOBAL OTHERS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 14. OTHER TOPICALS (AZELAIC ACID) MARKET, BY REGION, 2021-2030, MILLION USD
FIGURE 15. OTHERS OTC MARKET, BY REGION, 2021-2030, MILLION USD
FIGURE 16. OTHERS MARKET, BY REGION, 2021-2030, MILLION USD
FIGURE 17. GLOBAL ACNE MEDICATION MARKET, BY FORMULATION, 2021-2030, MILLION USD
FIGURE 18. TOPICAL MEDICATIONS MARKET, BY REGION, 2021-2030, MILLION USD
FIGURE 19. ORAL MEDICATIONS MARKET, BY REGION, 2021-2030, MILLION USD
FIGURE 20. GLOBAL ACNE MEDICATION MARKET, BY TYPE, 2021-2030, MILLION USD
FIGURE 21. PRESCRIPTION MEDICINES MARKET, BY REGION, 2021-2030, MILLION USD
FIGURE 22. OVER-THE-COUNTER (OTC )MEDICINES MARKET, BY REGION, 2021-2030, MILLION USD
FIGURE 23. GLOBAL ACNE MEDICATION MARKET, BY ACNE TYPE, 2021-2030, MILLION USD
FIGURE 24. INFLAMMATORY ACNE MARKET, BY REGION, 2021-2030, MILLION USD
FIGURE 25. NON-INFLAMMATORY ACNE MARKET, BY REGION, 2021-2030, MILLION USD
FIGURE 26. GLOBAL ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030, MILLION USD
FIGURE 27. GROCERY SHOPS MARKET, BY REGION, 2021-2030, MILLION USD
FIGURE 28. PHARMACIES & DRUG STORES MARKET, BY REGION, 2021-2030, MILLION USD
FIGURE 29. E-COMMERCE MARKET, BY REGION, 2021-2030, MILLION USD
FIGURE 30. GLOBAL ACNE MEDICATION MARKET, BY REGION, 2021-2030, MILLION USD
FIGURE 31. NORTH AMERICA ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 32. NORTH AMERICA RETINOIDS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 33. NORTH AMERICA ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 34. NORTH AMERICA OTHERS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 35. NORTH AMERICA ACNE MEDICATION MARKET, BY FORMULATION, 2021-2030, MILLION USD
FIGURE 36. NORTH AMERICA ACNE MEDICATION MARKET, BY TYPE, 2021-2030, MILLION USD
FIGURE 37. NORTH AMERICA ACNE MEDICATION MARKET, BY ACNE TYPE, 2021-2030, MILLION USD
FIGURE 38. NORTH AMERICA ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030, MILLION USD
FIGURE 39. NORTH AMERICA ACNE MEDICATION MARKET, BY COUNTRY, 2021-2030, MILLION USD
FIGURE 40. U.S. ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 41. U.S. RETINOIDS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 42. U.S. ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 43. U.S. OTHERS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 44. U.S. ACNE MEDICATION MARKET, BY FORMULATION, 2021-2030, MILLION USD
FIGURE 45. U.S. ACNE MEDICATION MARKET, BY TYPE, 2021-2030, MILLION USD
FIGURE 46. U.S. ACNE MEDICATION MARKET, BY ACNE TYPE, 2021-2030, MILLION USD
FIGURE 47. U.S. ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030, MILLION USD
FIGURE 48. CANADA ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 49. CANADA RETINOIDS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 50. CANADA ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 51. CANADA OTHERS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 52. CANADA ACNE MEDICATION MARKET, BY FORMULATION, 2021-2030, MILLION USD
FIGURE 53. CANADA ACNE MEDICATION MARKET, BY TYPE, 2021-2030, MILLION USD
FIGURE 54. CANADA ACNE MEDICATION MARKET, BY ACNE TYPE, 2021-2030, MILLION USD
FIGURE 55. CANADA ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030, MILLION USD
FIGURE 56. MEXICO ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 57. MEXICO RETINOIDS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 58. MEXICO ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 59. MEXICO OTHERS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 60. MEXICO ACNE MEDICATION MARKET, BY FORMULATION, 2021-2030, MILLION USD
FIGURE 61. MEXICO ACNE MEDICATION MARKET, BY TYPE, 2021-2030, MILLION USD
FIGURE 62. MEXICO ACNE MEDICATION MARKET, BY ACNE TYPE, 2021-2030, MILLION USD
FIGURE 63. MEXICO ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030, MILLION USD
FIGURE 64. EUROPE ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 65. EUROPE RETINOIDS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 66. EUROPE ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 67. EUROPE OTHERS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 68. EUROPE ACNE MEDICATION MARKET, BY FORMULATION, 2021-2030, MILLION USD
FIGURE 69. EUROPE ACNE MEDICATION MARKET, BY TYPE, 2021-2030, MILLION USD
FIGURE 70. EUROPE ACNE MEDICATION MARKET, BY ACNE TYPE, 2021-2030, MILLION USD
FIGURE 71. EUROPE ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030, MILLION USD
FIGURE 72. EUROPE ACNE MEDICATION MARKET, BY COUNTRY, 2021-2030, MILLION USD
FIGURE 73. GERMANY ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 74. GERMANY RETINOIDS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 75. GERMANY ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 76. GERMANY OTHERS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 77. GERMANY ACNE MEDICATION MARKET, BY FORMULATION, 2021-2030, MILLION USD
FIGURE 78. GERMANY ACNE MEDICATION MARKET, BY TYPE, 2021-2030, MILLION USD
FIGURE 79. GERMANY ACNE MEDICATION MARKET, BY ACNE TYPE, 2021-2030, MILLION USD
FIGURE 80. GERMANY ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030, MILLION USD
FIGURE 81. FRANCE ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 82. FRANCE RETINOIDS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 83. FRANCE ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 84. FRANCE OTHERS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 85. FRANCE ACNE MEDICATION MARKET, BY FORMULATION, 2021-2030, MILLION USD
FIGURE 86. FRANCE ACNE MEDICATION MARKET, BY TYPE, 2021-2030, MILLION USD
FIGURE 87. FRANCE ACNE MEDICATION MARKET, BY ACNE TYPE, 2021-2030, MILLION USD
FIGURE 88. FRANCE ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030, MILLION USD
FIGURE 89. UK ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 90. UK RETINOIDS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 91. UK ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 92. UK OTHERS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 93. UK ACNE MEDICATION MARKET, BY FORMULATION, 2021-2030, MILLION USD
FIGURE 94. UK ACNE MEDICATION MARKET, BY TYPE, 2021-2030, MILLION USD
FIGURE 95. UK ACNE MEDICATION MARKET, BY ACNE TYPE, 2021-2030, MILLION USD
FIGURE 96. UK ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030, MILLION USD
FIGURE 97. ITALY ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 98. ITALY RETINOIDS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 99. ITALY ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 100. ITALY OTHERS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 101. ITALY ACNE MEDICATION MARKET, BY FORMULATION, 2021-2030, MILLION USD
FIGURE 102. ITALY ACNE MEDICATION MARKET, BY TYPE, 2021-2030, MILLION USD
FIGURE 103. ITALY ACNE MEDICATION MARKET, BY ACNE TYPE, 2021-2030, MILLION USD
FIGURE 104. ITALY ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030, MILLION USD
FIGURE 105. SPAIN ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 106. SPAIN RETINOIDS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 107. SPAIN ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 108. SPAIN OTHERS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 109. SPAIN ACNE MEDICATION MARKET, BY FORMULATION, 2021-2030, MILLION USD
FIGURE 110. SPAIN ACNE MEDICATION MARKET, BY TYPE, 2021-2030, MILLION USD
FIGURE 111. SPAIN ACNE MEDICATION MARKET, BY ACNE TYPE, 2021-2030, MILLION USD
FIGURE 112. SPAIN ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030, MILLION USD
FIGURE 113. REST OF EUROPE ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 114. REST OF EUROPE RETINOIDS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 115. REST OF EUROPE ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 116. REST OF EUROPE OTHERS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 117. REST OF EUROPE ACNE MEDICATION MARKET, BY FORMULATION, 2021-2030, MILLION USD
FIGURE 118. REST OF EUROPE ACNE MEDICATION MARKET, BY TYPE, 2021-2030, MILLION USD
FIGURE 119. REST OF EUROPE ACNE MEDICATION MARKET, BY ACNE TYPE, 2021-2030, MILLION USD
FIGURE 120. REST OF EUROPE ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030, MILLION USD
FIGURE 121. ASIA-PACIFIC ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 122. ASIA-PACIFIC RETINOIDS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 123. ASIA-PACIFIC ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 124. ASIA-PACIFIC OTHERS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 125. ASIA-PACIFIC ACNE MEDICATION MARKET, BY FORMULATION, 2021-2030, MILLION USD
FIGURE 126. ASIA-PACIFIC ACNE MEDICATION MARKET, BY TYPE, 2021-2030, MILLION USD
FIGURE 127. ASIA-PACIFIC ACNE MEDICATION MARKET, BY ACNE TYPE, 2021-2030, MILLION USD
FIGURE 128. ASIA-PACIFIC ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030, MILLION USD
FIGURE 129. ASIA-PACIFIC ACNE MEDICATION MARKET, BY COUNTRY, 2021-2030, MILLION USD
FIGURE 130. JAPAN ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 131. JAPAN RETINOIDS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 132. JAPAN ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 133. JAPAN OTHERS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 134. JAPAN ACNE MEDICATION MARKET, BY FORMULATION, 2021-2030, MILLION USD
FIGURE 135. JAPAN ACNE MEDICATION MARKET, BY TYPE, 2021-2030, MILLION USD
FIGURE 136. JAPAN ACNE MEDICATION MARKET, BY ACNE TYPE, 2021-2030, MILLION USD
FIGURE 137. JAPAN ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030, MILLION USD
FIGURE 138. CHINA ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 139. CHINA RETINOIDS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 140. CHINA ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 141. CHINA OTHERS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 142. CHINA ACNE MEDICATION MARKET, BY FORMULATION, 2021-2030, MILLION USD
FIGURE 143. CHINA ACNE MEDICATION MARKET, BY TYPE, 2021-2030, MILLION USD
FIGURE 144. CHINA ACNE MEDICATION MARKET, BY ACNE TYPE, 2021-2030, MILLION USD
FIGURE 145. CHINA ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030, MILLION USD
FIGURE 146. INDIA ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 147. INDIA RETINOIDS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 148. INDIA ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 149. INDIA OTHERS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 150. INDIA ACNE MEDICATION MARKET, BY FORMULATION, 2021-2030, MILLION USD
FIGURE 151. INDIA ACNE MEDICATION MARKET, BY TYPE, 2021-2030, MILLION USD
FIGURE 152. INDIA ACNE MEDICATION MARKET, BY ACNE TYPE, 2021-2030, MILLION USD
FIGURE 153. INDIA ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030, MILLION USD
FIGURE 154. AUSTRALIA ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 155. AUSTRALIA RETINOIDS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 156. AUSTRALIA ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 157. AUSTRALIA OTHERS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 158. AUSTRALIA ACNE MEDICATION MARKET, BY FORMULATION, 2021-2030, MILLION USD
FIGURE 159. AUSTRALIA ACNE MEDICATION MARKET, BY TYPE, 2021-2030, MILLION USD
FIGURE 160. AUSTRALIA ACNE MEDICATION MARKET, BY ACNE TYPE, 2021-2030, MILLION USD
FIGURE 161. AUSTRALIA ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030, MILLION USD
FIGURE 162. SOUTH KOREA ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 163. SOUTH KOREA RETINOIDS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 164. SOUTH KOREA ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 165. SOUTH KOREA OTHERS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 166. SOUTH KOREA ACNE MEDICATION MARKET, BY FORMULATION, 2021-2030, MILLION USD
FIGURE 167. SOUTH KOREA ACNE MEDICATION MARKET, BY TYPE, 2021-2030, MILLION USD
FIGURE 168. SOUTH KOREA ACNE MEDICATION MARKET, BY ACNE TYPE, 2021-2030, MILLION USD
FIGURE 169. SOUTH KOREA ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030, MILLION USD
FIGURE 170. REST OF ASIA-PACIFIC ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 171. REST OF ASIA-PACIFIC RETINOIDS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 172. REST OF ASIA-PACIFIC ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 173. REST OF ASIA-PACIFIC OTHERS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 174. REST OF ASIA-PACIFIC ACNE MEDICATION MARKET, BY FORMULATION, 2021-2030, MILLION USD
FIGURE 175. REST OF ASIA-PACIFIC ACNE MEDICATION MARKET, BY TYPE, 2021-2030, MILLION USD
FIGURE 176. REST OF ASIA-PACIFIC ACNE MEDICATION MARKET, BY ACNE TYPE, 2021-2030, MILLION USD
FIGURE 177. REST OF ASIA-PACIFIC ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030, MILLION USD
FIGURE 178. REST OF WORLD ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 179. REST OF WORLD RETINOIDS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 180. REST OF WORLD ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 181. REST OF WORLD OTHERS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 182. REST OF WORLD ACNE MEDICATION MARKET, BY FORMULATION, 2021-2030, MILLION USD
FIGURE 183. REST OF WORLD ACNE MEDICATION MARKET, BY TYPE, 2021-2030, MILLION USD
FIGURE 184. REST OF WORLD ACNE MEDICATION MARKET, BY ACNE TYPE, 2021-2030, MILLION USD
FIGURE 185. REST OF WORLD ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030, MILLION USD
FIGURE 186. REST OF WORLD ACNE MEDICATION MARKET, BY COUNTRY, 2021-2030, MILLION USD
FIGURE 187. BRAZIL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 188. BRAZIL RETINOIDS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 189. BRAZIL ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 190. BRAZIL OTHERS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 191. BRAZIL ACNE MEDICATION MARKET, BY FORMULATION, 2021-2030, MILLION USD
FIGURE 192. BRAZIL ACNE MEDICATION MARKET, BY TYPE, 2021-2030, MILLION USD
FIGURE 193. BRAZIL ACNE MEDICATION MARKET, BY ACNE TYPE, 2021-2030, MILLION USD
FIGURE 194. BRAZIL ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030, MILLION USD
FIGURE 195. KINGDOM OF SAUDI ARABIA (KSA) ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 196. KINGDOM OF SAUDI ARABIA (KSA) RETINOIDS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 197. KINGDOM OF SAUDI ARABIA (KSA) ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 198. KINGDOM OF SAUDI ARABIA (KSA) OTHERS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 199. KINGDOM OF SAUDI ARABIA (KSA) ACNE MEDICATION MARKET, BY FORMULATION, 2021-2030, MILLION USD
FIGURE 200. KINGDOM OF SAUDI ARABIA (KSA) ACNE MEDICATION MARKET, BY TYPE, 2021-2030, MILLION USD
FIGURE 201. KINGDOM OF SAUDI ARABIA (KSA) ACNE MEDICATION MARKET, BY ACNE TYPE, 2021-2030, MILLION USD
FIGURE 202. KINGDOM OF SAUDI ARABIA (KSA) ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030, MILLION USD
FIGURE 203. SOUTH AFRICA ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 204. SOUTH AFRICA RETINOIDS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 205. SOUTH AFRICA ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 206. SOUTH AFRICA OTHERS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 207. SOUTH AFRICA ACNE MEDICATION MARKET, BY FORMULATION, 2021-2030, MILLION USD
FIGURE 208. SOUTH AFRICA ACNE MEDICATION MARKET, BY TYPE, 2021-2030, MILLION USD
FIGURE 209. SOUTH AFRICA ACNE MEDICATION MARKET, BY ACNE TYPE, 2021-2030, MILLION USD
FIGURE 210. SOUTH AFRICA ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030, MILLION USD
FIGURE 211. REMAINING COUNTRIES ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 212. REMAINING COUNTRIES RETINOIDS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 213. REMAINING COUNTRIES ANTIBIOTICS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 214. REMAINING COUNTRIES OTHERS MARKET, BY THERAPEUTIC CLASS, 2021-2030, MILLION USD
FIGURE 215. REMAINING COUNTRIES ACNE MEDICATION MARKET, BY FORMULATION, 2021-2030, MILLION USD
FIGURE 216. REMAINING COUNTRIES ACNE MEDICATION MARKET, BY TYPE, 2021-2030, MILLION USD
FIGURE 217. REMAINING COUNTRIES ACNE MEDICATION MARKET, BY ACNE TYPE, 2021-2030, MILLION USD
FIGURE 218. REMAINING COUNTRIES ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030, MILLION USD
FIGURE 219. PROCTER & GAMBLE: NET SALES, 2019–2021 ($MILLION)
FIGURE 220. PROCTER & GAMBLE: PRIMARY MARKET COMPETITORS
FIGURE 221. UNILEVER PLC: NET SALES, 2019–2021 ($MILLION)
FIGURE 222. UNILEVER PLC: PRIMARY MARKET COMPETITORS
FIGURE 223. OBAGI MEDICAL: PRIMARY MARKET COMPETITORS
FIGURE 224. AVON PRODUCTS, INC: PRIMARY MARKET COMPETITORS
FIGURE 225. HERBALIFE NUTRITION: NET SALES, 2019–2021 ($MILLION)
FIGURE 226. HERBALIFE NUTRITION: PRIMARY MARKET COMPETITORS
FIGURE 227. BEIERSDORF AG: NET SALES, 2019–2021 ($MILLION)
FIGURE 228. BEIERSDORF AG: PRIMARY MARKET COMPETITORS
FIGURE 229. ABBVIE INC.: PRIMARY MARKET COMPETITORS
FIGURE 230. GALDERMA.: PRIMARY MARKET COMPETITORS
FIGURE 231. ESTEE LAUDER INC.: NET SALES, 2019–2021 ($MILLION)
FIGURE 232. ESTEE LAUDER INC.: PRIMARY MARKET COMPETITORS
FIGURE 233. GLAXOSMITHKLINE PLC: NET SALES, 2019-2021 ($ MILLION)
FIGURE 234. GLAXOSMITHKLINE PLC: PRIMARY MARKET COMPETITORS
FIGURE 235. JOHNSON & JOHNSON, 2019–2021 ($MILLION)
FIGURE 236. JOHNSON & JOHNSON: PRIMARY MARKET COMPETITORS
FIGURE 237. NEUTROGENA: PRIMARY MARKET COMPETITORS
FIGURE 238. HIMALAYA WELLNESS COMPANY: PRIMARY MARKET COMPETITORS
FIGURE 239. ALMIRALL S.A.: NET SALES, 2019–2021 (USD MILLION)
FIGURE 240. ALMIRALL S.A.: PRIMARY MARKET COMPETITORS
FIGURE 241. BAUSCH HEALTH COMPANIES INC.: NET SALES, 2019–2021 (USD MILLION)
FIGURE 242. BAUSCH HEALTH COMPANIES INC.: PRIMARY MARKET COMPETITORS
FIGURE 243. AMWAY CORP: PRIMARY MARKET COMPETITORS
FIGURE 244. ABBOTT LABORATORIES: NET SALES, 2019–2021 ($ MILLION)
FIGURE 245. ABBOTT LABORATORIES: PRIMARY MARKET COMPETITORS
FIGURE 246. TEVA PHARMACEUTICALS: NET SALES, 2019–2021 ($ MILLION)
FIGURE 247. TEVA PHARMACEUTICALS: PRIMARY MARKET COMPETITORS
FIGURE 248. SUN PHARMA: NET SALES, 2019–2021 ($MILLION)
FIGURE 249. SUN PHARMA: PRIMARY MARKET COMPETITORS
FIGURE 250. GLENMARK PHARMACEUTICALS, 2019–2021 ($MILLION)
FIGURE 251. GLENMARK PHARMACEUTICALS: PRIMARY MARKET COMPETITORS
FIGURE 252. VIATRIS: NET SALES, 2019–2021 ($MILLION)
FIGURE 253. VIATRIS: PRIMARY MARKET COMPETITORS
FIGURE 254. PFIZER INC.: NET SALES, 2019–2021 ($MILLION)
FIGURE 255. PFIZER INC.: PRIMARY MARKET COMPETITORS
FIGURE 256. MAYNE PHARMA GROUP LIMITED: NET SALES, 2019–2021 ($MILLION)
FIGURE 257. MAYNE PHARMA GROUP LIMITED: PRIMARY MARKET COMPETITORS
FIGURE 258. CLINIQUE LABORATORIES: PRIMARY MARKET COMPETITORS
FIGURE 259. COLGATE-PALMOLIVE: NET SALES, 2019–2021 ($MILLION)
FIGURE 260. COLGATE-PALMOLIVE: PRIMARY MARKET COMPETITORS
FIGURE 261. L’OREAL: NET SALES, 2019–2021 ($MILLION)
FIGURE 262. L’OREAL: PRIMARY MARKET COMPETITORS